On January 31st, 2024, the recruitment process for the PreFIT project officially came to an end.
The three study sites, Centro de Investigação em Saúde de Manhiça (CISM) in Mozambique, Makerere University in Uganda, and Stellenbosch University (SU) in South Africa were commended for their dedication and hard work.
Prefit, Predicting the Future: Incipient Tuberculosis, aims to reduce the morbidity and mortality of tuberculosis in Africa by detecting the disease early, before symptoms appear.
We are excited about the results we will get from the follow-up of our participants.